Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Jan 24:9:139-50.
doi: 10.2147/COPD.S38938. eCollection 2014.

Clinical issues of mucus accumulation in COPD

Frederick L Ramos  1 , Jason S Krahnke  1 , Victor Kim  1
Affiliations
Review

Clinical issues of mucus accumulation in COPD

Frederick L Ramos et al. Int J Chron Obstruct Pulmon Dis. .

Abstract

Airway mucus is part of the lung's native immune function that traps particulates and microorganisms, enabling their clearance from the lung by ciliary transport and cough. Mucus hypersecretion and chronic productive cough are the features of the chronic bronchitis and chronic obstructive pulmonary disease (COPD). Overproduction and hypersecretion by goblet cells and the decreased elimination of mucus are the primary mechanisms responsible for excessive mucus in chronic bronchitis. Mucus accumulation in COPD patients affects several important outcomes such as lung function, health-related quality of life, COPD exacerbations, hospitalizations, and mortality. Nonpharmacologic options for the treatment of mucus accumulation in COPD are smoking cessation and physical measures used to promote mucus clearance. Pharmacologic therapies include expectorants, mucolytics, methylxanthines, beta-adrenergic receptor agonists, anticholinergics, glucocorticoids, phosphodiesterase-4 inhibitors, antioxidants, and antibiotics.

Keywords: chronic bronchitis; chronic obstructive pulmonary disease; mucus; sputum.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Causes of excessive mucus in COPD. Notes: Reprinted with permission of the American Thoracic Society. Copyright © 2013 American Thoracic Society. Kim V, Criner GJ, 2013, Chronic bronchitis and chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 187(3):228–237. Official journal of the American Thoracic Society. Abbreviations: PEF, peak expiratory flow; COPD, chronic obstructive pulmonary disease.
Figure 2
Figure 2
MM and smooth muscle hypertrophy in a small airway from a COPD patient. Note: Hematoxylin and eosin stain. Abbreviations: MM, mucous metaplasia; SMH, smooth muscle hypertrophy; COPD, chronic pulmonary disease.
Figure 3
Figure 3
Goblet cell hyperplasia. Notes: Periodic acid Schiff–Alcian Blue stain. Higher magnification of a small airway quadrant is shown here. Goblet cells appear in an intense blue–purple color with periodic acid Schiff–Alcian Blue stain.
See this image and copyright information in PMC

Comment in

  • Clinical issues of mucus accumulation in COPD.
    Osadnik CR, McDonald CF, Holland AE. Osadnik CR, et al. Int J Chron Obstruct Pulmon Dis. 2014 Mar 25;9:301-2. doi: 10.2147/COPD.S61797. eCollection 2014. Int J Chron Obstruct Pulmon Dis. 2014. PMID: 24741301 Free PMC article. No abstract available.

References

    1. Vestbo J, Hurd SS, Agustí AG, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–365. - PubMed
    1. World Health Organization . World Health Statistics 2008. Geneva, Switzerland: World Health Organization; 2008. [Accessed July 23, 2013]. Available from: http://www.who.int/whosis/whostat/EN_WHS08_Full.pdf.
    1. Voynow JA, Rubin BK. Mucins, mucus, and sputum. Chest. 2009;135(2):505–512. - PubMed
    1. Shade D, Jr, Cordova FC. Normal lung structure. In: Criner GJ, D’Alonzo GE, editors. Pulmonary Pathophysiology. 1st ed. 1999. p. 20.
    1. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med. 2010;363(23):2233–2247. - PMC - PubMed

MeSH terms